NCT06782217View on ClinicalTrials.gov

Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

February 1, 2027

Conditions
Allergy, Insect VenomAllergy Insect StingingInsect Sting Allergy
Interventions
BIOLOGICAL

VENOX

Treatment with allergy vaccine againts Vespula spp. (wasp) or Apis mellifera (bee), as per clinical indication.

Trial Locations (9)

10600

RECRUITING

Hospital Virgen del Puerto Plasencia, Plasencia

15006

RECRUITING

Hospital de A Coruña, A Coruña

15405

NOT_YET_RECRUITING

Hospital Arquitecto Marcide, Ferrol

27003

RECRUITING

Hospital Universitario Lucus Augusti, Lugo

27400

RECRUITING

Hospital Comarcal de Monforte de Lemos, Monforte de Lemos

27880

RECRUITING

Hospital Público Da Mariña, Burela de Cabo

32005

RECRUITING

Complejo Hospitalario Universitario de Ourense, Ourense

36071

RECRUITING

Hospital Universitario de Pontevedra, Pontevedra

08035

RECRUITING

Hospital Vall d' Hebron, Barcelona

Sponsors

Lead Sponsor

Inmunotek S.L.
All Listed Sponsors
lead

Inmunotek S.L.

INDUSTRY

NCT06782217 - Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy | Biotech Hunter | Biotech Hunter